MelaTocin Essence. Anti-pigmentation & Anti-melatma Care
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- mesotherapy, pigment, whitening, melasma
- Category
- Skin Care Serum
Product name | MelaTocin Essence. Anti-pigmentation & Anti-melatma Care | Certification | - |
---|---|---|---|
Category | Skin Care Serum | Ingredients | - |
Keyword | mesotherapy , pigment , whitening , melasma | Unit Size | - |
Brand name | - | Unit Weigh | - |
origin | South Korea | Stock | - |
Supply type | - | HS code | 3304991000 |
Product Information
Solution for the corrective dark spot by Vitamin C and Tranexamic Acid
- Intensive Whitening
- Dark Spot
- PIH
- Melasma
- Skin brightening
- Started domestic sales in 2013
- Started exporting overseas since 2014 (China, Hong Kong, Russia)
- Exported to about 10 countries as of 2018
(Vietnam, Malaysia, Indonesia, Singapore, China, Russia, Turkey, Iraq, UAE)
- Total sales of about 8,000 boxes in 2017 (estimated 7-80,000 times)
2. Point
- Ascorbic acid (Vitamin C) is very unstable and easily oxidized and converted to
DHA (dehydroascorbic acid), losing the properties of vitamin C.
- MelaTocin enhanced the preservative capacity of Ascorbic acid by applying its
own neutralization preservation method to prevent the easy oxidation of
Ascorbic acid.
- Especially effective in improving liver blemishes due to containing tranexamic acid
B2B Trade
Price (FOB) | Negotiable | transportation | - |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | Negotiable | Shipping time | Negotiable |
- President
- KIM SEOK SUN
- Address
- 13 Sinpyeong-ro Jijeong-myeon Wonju-si Gangwon, Wonju-si, Gangwon-do, Korea
- Product Category
- Beauty Equipment,Other Beauty Equipment,Other Beauty Products,Pharmaceuticals
- Year Established
- 2005
- No. of Total Employees
- 51-100
- Company introduction
-
BR PHARM is pharmaceutical and cosmeceutical company specialized in developing and manufacturing the PDRN(Polydeoxyribonucelotide) APIs and its finished products for the advancement of Regenerative & Aesthetic Medicine based on the research with many eminent dermatologists and plastic surgeons. We, BR PHARM, will do our best in whatever meets the customer expectation and are ready to lead cosmeceutical markets.
- Main Markets
-
China
- Main Product